Laboratory diagnosis of emerging human coronavirus infections–the state of the art

Emerging Microbes and Infections

Volumn 9, Issue 1, 2020, Pages 747-756

  Loeffelholz, Michael J ^a   Tang, Yi Wei ^b  

^a CEPHEID   (United States)

^b Danaher Diagnostic Platform ^*  (China)

Author keywords

COVID 19; Human coronavirus; POCT; real time PCR; SARS CoV 2; serology

Indexed keywords

BIOSAFETY; BRONCHOSCOPY; CASE FATALITY RATE; CELL CULTURE; CHINA; CORONAVIRUS DISEASE 2019; COUGHING; DIAGNOSTIC ACCURACY; DISEASE COURSE; DYSPNEA; EPIDEMIC; FEVER; GOLD STANDARD; HEADACHE; HUMAN; INCUBATION TIME; LABORATORY DIAGNOSIS; LABORATORY TECHNIQUE; MOLECULAR DIAGNOSIS; MORBIDITY; MORTALITY RATE; MYALGIA; NASOPHARYNX; NONHUMAN; POINT OF CARE TESTING; PRIORITY JOURNAL; PUBLIC HEALTH; RESPIRATORY DISTRESS; REVIEW; SEROLOGY; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SPUTUM; THORAX RADIOGRAPHY; THROAT CULTURE; VIRUS DETECTION; VIRUS PNEUMONIA; BETACORONAVIRUS; COMMUNICABLE DISEASE; CORONAVIRUS INFECTION; GENETICS; IMMUNOLOGY; MORTALITY; PANDEMIC; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEVERE ACUTE RESPIRATORY SYNDROME; SPECIMEN HANDLING;

VIRUS ANTIGEN;

ANTIGENS, VIRAL; BETACORONAVIRUS; CLINICAL LABORATORY TECHNIQUES; COMMUNICABLE DISEASES, EMERGING; CORONAVIRUS INFECTIONS; DISEASE OUTBREAKS; HUMANS; PANDEMICS; PNEUMONIA, VIRAL; POINT-OF-CARE TESTING; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEROLOGIC TESTS; SEVERE ACUTE RESPIRATORY SYNDROME; SPECIMEN HANDLING;

EID: 85082623351     PISSN: None     EISSN: 22221751     Source Type: Journal    
DOI: 10.1080/22221751.2020.1745095     Document Type: Review

References (70)

1. Su S, Wong G, Shi W, et al. Epidemiology, genetic recombination, and Pathogenesis of coronaviruses. Trends Microbiol 2016;24(6):490–502. doi:410.1016/j.tim.2016.1003.1003 doi: 10.1016/j.tim.2016.03.003
2. Ksiazek TG, Erdman D, Goldsmith CS, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003;348(20):1953–1966. doi:1910.1056/NEJMoa030781.
3. Peiris JS, Lai ST, Poon LL, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 2003;361(9366):1319–1325. doi:1310.1016/s0140-6736(1303)13077-13072 doi: 10.1016/S0140-6736(03)13077-2
4. Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis. 2013;13(9):752–761. doi:710.1016/S1473-3099(1013)70204-70204 doi: 10.1016/S1473-3099(13)70204-4
5. Drosten C, Seilmaier M, Corman VM, et al. Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis. 2013;13(9):745–751. doi:710.1016/S1473-3099(1013)70154-70153 doi: 10.1016/S1473-3099(13)70154-3
6. Zaki AM, van Boheemen S, Bestebroer TM, et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367(19):1814–1820. doi:1810.1056/NEJMoa1211721.
7. Lu H, Stratton CW, Tang YW., Outbreak of pneumonia of unknown Etiology in Wuhan China: the Mystery and the Miracle. J Med Virol. 2020;92(4):401–402. doi: 10.1002/jmv.25678
8. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733. doi: 10.1056/NEJMoa2001017
9. Anonymous. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020. Epub ahead of print.
10. Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;30(20):30251–30258.
11. Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–273. doi: 10.1038/s41586-020-2012-7
12. Gaunt ER, Hardie A, Claas EC, et al. Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method. J Clin Microbiol. 2010;48(8):2940–2947. doi:2910.1128/JCM.00636-00610 doi: 10.1128/JCM.00636-10
13. Wong G, Liu W, Liu Y, et al. MERS, SARS, and Ebola: The role of super-spreaders in infectious disease. Cell Host Microbe. 2015;18(4):398–401. doi:310.1016/j.chom.2015.1009.1013 doi: 10.1016/j.chom.2015.09.013
14. Sun J, He W, Wang L, et al. COVID-19: epidemiology, evolution, and cross-disciplinary perspectives. Trends Mol Med. 2020. Epub ahead of print.
15. Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020. Epub ahead of print.
16. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;24(20):30183–30185.
17. Wang W, Tang J, Wei F., Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. J Med Virol. 2020;92(4):441–447. doi: 10.1002/jmv.25689
18. Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020. Epub ahead of print.
19. Tian S, Hu N, Lou J, et al. Characteristics of COVID-19 infection in Beijing. J Infect. 2020;27(20):30101–30108.
20. Holshue ML, DeBolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020;382(10):929–936. doi: 10.1056/NEJMoa2001191
21. Shen K, Yang Y, Wang T, et al. Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts’ consensus statement. World J Pediatr. 2020. Epub ahead of print.
22. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020. Epub ahead of print.
23. Charlton CL, Babady E, Ginocchio CC, et al. Practical guidance for clinical microbiology laboratories: viruses causing acute respiratory tract infections. Clin Microbiol Rev. 2019;32(1). doi:00010.01128/CMR.00042-00018 doi: 10.1128/CMR.00042-18
24. Falsey AR, Formica MA, Walsh EE., Simple method for combining sputum and nasal samples for virus detection by reverse transcriptase PCR. J Clin Microbiol. 2012;50(8):2835. doi:2810.1128/JCM.01473-01412 doi: 10.1128/JCM.01473-12
25. Wang W, Xu Y, Gao R, et al. Detection of SARS-CoV-2 in different types of clinical specimens. Jama. 2020. Epub ahead of print.
26. Cheng PK, Wong DA, Tong LK, et al. Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome. Lancet. 2004;363(9422):1699–1700. doi:1610.1016/S0140-6736(1604)16255-16257 doi: 10.1016/S0140-6736(04)16255-7
27. Al-Abdely HM, Midgley CM, Alkhamis AM, et al. Middle East respiratory syndrome coronavirus infection dynamics and antibody Responses among clinically Diverse patients, Saudi Arabia. Emerg Infect Dis. 2019;25(4):753–766. doi:710.3201/eid2504.181595.
28. Poissy J, Goffard A, Parmentier-Decrucq E, et al. Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases. J Clin Virol. 2014;61(2):275–278. doi:210.1016/j.jcv.2014.1007.1002 doi: 10.1016/j.jcv.2014.07.002
29. Xu D, Zhang Z, Jin L, et al. Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase. Eur J Clin Microbiol Infect Dis. 2005;24(3):165–171. doi:110.1007/s10096-10005-11299-10095 doi: 10.1007/s10096-005-1299-5
30. To KK, Tsang OT, Chik-Yan Yip C, et al. Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis. 2020. Epub ahead of print.
31. Hamre D, Kindig DA, Mann J., Growth and intracellular development of a new respiratory virus. J Virol. 1967;1(4):810–816. doi: 10.1128/JVI.1.4.810-816.1967
32. Tyrrell DAJ, Bynoe ML., Cultivation of a novel type of common-cold virus in organ cultures. Br Med J. 1965;1(5448):1467–1470. doi: 10.1136/bmj.1.5448.1467
33. Chen Y, Chan KH, Hong C, et al. A highly specific rapid antigen detection assay for on-site diagnosis of MERS. J Infect. 2016;73(1):82–84. doi:10.1016/j.jinf.2016.1004.1014 doi: 10.1016/j.jinf.2016.04.014
34. Lau SK, Woo PC, Wong BH, et al. Detection of severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in SARS patients by enzyme-linked immunosorbent assay. J Clin Microbiol. 2004;42(7):2884–2889. doi:2810.1128/JCM.2842.2887.2884-2889.2004 doi: 10.1128/JCM.42.7.2884-2889.2004
35. Sastre P, Dijkman R, Camunas A, et al. Differentiation between human coronaviruses NL63 and 229E using a novel double-antibody sandwich enzyme-linked immunosorbent assay based on specific monoclonal antibodies. Clin Vaccine Immunol. 2011;18(1):113–118. doi:110.1128/CVI.00355-00310 doi: 10.1128/CVI.00355-10
36. Liu IJ, Chen PJ, Yeh SH, et al. Immunofluorescence assay for detection of the nucleocapsid antigen of the severe acute respiratory syndrome (SARS)-associated coronavirus in cells derived from throat wash samples of patients with SARS. J Clin Microbiol. 2005;43(5):2444–2448. doi:2410.1128/JCM.2443.2445.2444-2448.2005 doi: 10.1128/JCM.43.5.2444-2448.2005
37. Sizun J, Arbour N, Talbot PJ., Comparison of immunofluorescence with monoclonal antibodies and RT-PCR for the detection of human coronaviruses 229E and OC43 in cell culture. J Virol Methods. 1998;72(2):145–152. doi:110.1016/s0166-0934(1098)00013-00015 doi: 10.1016/S0166-0934(98)00013-5
38. Li W, Liu L, Chen L, et al. Evaluation of a commercial colloidal gold assay for detection of influenza A and B virus in children's respiratory specimens. Fetal Pediatr Pathol. 2019;15:1–6. doi: 10.1080/15513815.2019.1639088
39. Bruning AHL, Aatola H, Toivola H, et al. Rapid detection and monitoring of human coronavirus infections. New Microbes New Infect. 2018;24:52–55. doi:10.1016/j.nmni.2018.1004.1007 doi: 10.1016/j.nmni.2018.04.007
40. Chan CM, Tse H, Wong SS, et al. Examination of seroprevalence of coronavirus HKU1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virus. J Clin Virol. 2009;45(1):54–60. doi:10.1016/j.jcv.2009.1002.1011 doi: 10.1016/j.jcv.2009.02.011
41. Shao X, Guo X, Esper F, et al. Seroepidemiology of group I human coronaviruses in children. J Clin Virol. 2007;40(3):207–213. doi:210.1016/j.jcv.2007.1008.1007 doi: 10.1016/j.jcv.2007.08.007
42. Zhang W, Du RH, Li B, et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect. 2020;9(1):386–389. doi:310.1080/22221751.22222020.21729071 doi: 10.1080/22221751.2020.1729071
43. Briese T, Mishra N, Jain K, et al. Middle East respiratory syndrome coronavirus quasispecies that include homologues of human isolates revealed through whole-genome analysis and virus cultured from dromedary camels in Saudi Arabia. mBio. 2014;5(3):e01146–e01114. doi:01110.01128/mBio.01146-01114 doi: 10.1128/mBio.01146-14
44. Chen L, Liu W, Zhang Q, et al. RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak. Emerg Microbes Infect. 2020;9(1):313–319. doi:310.1080/22221751.22222020.21725399 doi: 10.1080/22221751.2020.1725399
45. Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265–269. doi: 10.1038/s41586-020-2008-3
46. Ren LL, Wang YM, Wu ZQ, et al. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin Med J. 2020. Epub ahead of print.
47. Wu X, Cai Y, Huang X, et al. Co-infection with SARS-CoV-2 and influenza A virus in patient with pneumonia, China. Emerg Infect Dis. 2020;26(6). doi: 10.3201/eid2606.200299
48. Das S, Dunbar S, Tang YW., Laboratory diagnosis of respiratory tract infections in children - the State of the Art. Front Microbiol. 2018;9:2478. doi:10.3389/fmicb.2018.02478.
49. Mahony JB, Richardson S., Molecular diagnosis of severe acute respiratory syndrome: the state of the art. J Mol Diagn. 2005;7(5):551–559. doi:510.1016/S1525-1578(1010)60587-60589 doi: 10.1016/S1525-1578(10)60587-9
50. Wu W, Tang YW., Emerging molecular assays for detection and characterization of respiratory viruses. Clin Lab Med. 2009;29(4):673–693. doi:610.1016/j.cll.2009.1007.1005 doi: 10.1016/j.cll.2009.07.005
51. Yan Y, Zhang S, Tang YW., Molecular assays for the detection and characterization of respiratory viruses. Semin Respir Crit Care Med. 2011;32(4):512–526. doi:510.1055/s-0031-1283288.
52. Zlateva KT, Coenjaerts FE, Crusio KM, et al. No novel coronaviruses identified in a large collection of human nasopharyngeal specimens using family-wide CODEHOP-based primers. Arch Virol. 2013;158(1):251–255. doi:210.1007/s00705-00012-01487-00704 doi: 10.1007/s00705-012-1487-4
53. Kuypers J, Martin ET, Heugel J, et al. Clinical disease in children associated with newly described coronavirus subtypes. Pediatrics. 2007;119(1):e70–e76. doi:10.1542/peds.2006-1406.
54. Woo PC, Lau SK, Chu CM, et al. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol. 2005;79(2):884–895. doi:810.1128/JVI.1179.1122.1884-1895.2005 doi: 10.1128/JVI.79.2.884-895.2005
55. Babady NE, England MR, Jurcic Smith KL, et al. Multicenter evaluation of the ePlex respiratory pathogen panel for the detection of viral and bacterial respiratory tract pathogens in nasopharyngeal swabs. J Clin Microbiol. 2018;56(2). doi:01610.01128/JCM.01658-01617 doi: 10.1128/JCM.01658-17
56. Babady NE, Mead P, Stiles J, et al. Comparison of the Luminex xTAG RVP fast assay and the Idaho Technology FilmArray RP assay for detection of respiratory viruses in pediatric patients at a cancer hospital. J Clin Microbiol. 2012;50(7):2282–2288. doi:2210.1128/JCM.06186-06111 doi: 10.1128/JCM.06186-11
57. Tang YW, Gonsalves S, Sun JY, et al. Clinical evaluation of the Luminex NxTAG respiratory pathogen panel. J Clin Microbiol. 2016;54(7):1912–1914. doi:1910.1128/JCM.00482-00416 doi: 10.1128/JCM.00482-16
58. Liu R, Han H, Liu F, et al. Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020. Clin Chim Acta. 2020. Epub ahead of print.
59. Rothe C, Schunk M, Sothmann P, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020;382(10):970–971. doi: 10.1056/NEJMc2001468
60. Corman VM, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25(3). doi:10.2807/1560-7917.ES.2020.2825.2803.2000045 doi: 10.2807/1560-7917.ES.2020.25.3.2000045
61. Chan JF, Kok KH, Zhu Z, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020;9(1):221–236. doi:210.1080/22221751.22222020.21719902 doi: 10.1080/22221751.2020.1719902
62. Raftery P, Condell O, Wasunna C, et al. Establishing Ebola virus disease (EVD) diagnostics using GeneXpert technology at a mobile laboratory in Liberia: impact on outbreak response, case management and laboratory systems strengthening. PLoS Negl Trop Dis. 2018;12(1):e0006135. doi:0006110.0001371/journal.pntd.0006135 doi: 10.1371/journal.pntd.0006135
63. Kozel TR, Burnham-Marusich AR., Point-of-care testing for infectious diseases: past, present, and future. J Clin Microbiol. 2017;55(8):2313–2320. doi:2310.1128/JCM.00476-00417 doi: 10.1128/JCM.00476-17
64. Nie S, Roth RB, Stiles J, et al. Evaluation of Alere i influenza A&B for rapid detection of influenza viruses A and B. J Clin Microbiol. 2014;52(9):3339–3344. doi:3310.1128/JCM.01132-01114 doi: 10.1128/JCM.01132-14
65. Wang H, Deng J, Tang YW., Profile of the Alere i influenza A & B assay: a pioneering molecular point-of-care test. Expert Rev Mol Diagn. 2018;18(5):403–409. doi:410.1080/14737159.14732018.11466703 doi: 10.1080/14737159.2018.1466703
66. Ling L, Kaplan SE, Lopez JC, et al. Parallel validation of three molecular devices for simultaneous detection and identification of influenza A and B and respiratory syncytial viruses. J Clin Microbiol. 2018;56(3). doi:01610.01128/JCM.01691-01617 doi: 10.1128/JCM.01691-17
67. Beal SG, Posa M, Gaffar M, et al. Performance and impact of a CLIA-waived, point-of-care respiratory PCR Panel in a pediatric clinic. Pediatr Infect Dis J. 2020;39(3):188–191. doi:110.1097/INF.0000000000002544.
68. van der Hoek L, Pyrc K, Jebbink MF, et al. Identification of a new human coronavirus. Nat Med. 2004;10(4):368–373. doi:310.1038/nm1024.
69. Chan JF, Choi GK, Tsang AK, et al. Development and evaluation of novel real-time reverse transcription-PCR assays with Locked nucleic acid probes targeting leader sequences of human-pathogenic coronaviruses. J Clin Microbiol. 2015;53(8):2722–2726. doi:2710.1128/JCM.01224-01215 doi: 10.1128/JCM.01224-15
70. Dare RK, Fry AM, Chittaganpitch M, et al. Human coronavirus infections in rural Thailand: a comprehensive study using real-time reverse-transcription polymerase chain reaction assays. J Infect Dis. 2007;196(9):1321–1328. doi:1310.1086/521308.